Verastem Stock EBITDA
VSTM Stock | USD 3.93 0.14 3.69% |
Verastem fundamentals help investors to digest information that contributes to Verastem's financial success or failures. It also enables traders to predict the movement of Verastem Stock. The fundamental analysis module provides a way to measure Verastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verastem stock.
Last Reported | Projected for Next Year | ||
EBITDA | -83.2 M | -87.3 M |
Verastem | EBITDA |
Verastem Company EBITDA Analysis
Verastem's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Verastem EBITDA | (83.17 M) |
Most of Verastem's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Verastem EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Verastem is extremely important. It helps to project a fair market value of Verastem Stock properly, considering its historical fundamentals such as EBITDA. Since Verastem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Verastem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Verastem's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
Verastem Ebitda
According to the company disclosure, Verastem reported earnings before interest,tax, depreciation and amortization of (83.17 Million). This is 109.48% lower than that of the Biotechnology sector and 183.04% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.13% higher than that of the company.
Verastem EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verastem's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Verastem could also be used in its relative valuation, which is a method of valuing Verastem by comparing valuation metrics of similar companies.Verastem is currently under evaluation in ebitda category among its peers.
Verastem Current Valuation Drivers
We derive many important indicators used in calculating different scores of Verastem from analyzing Verastem's financial statements. These drivers represent accounts that assess Verastem's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Verastem's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 99.9M | 326.6M | 357.5M | 77.5M | 69.7M | 66.2M | |
Enterprise Value | 164.0M | 281.4M | 259.5M | 29.6M | 34.0M | 32.3M |
Verastem ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Verastem's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Verastem's managers, analysts, and investors.Environmental | Governance | Social |
Verastem Institutional Holders
Institutional Holdings refers to the ownership stake in Verastem that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Verastem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Verastem's value.Shares | Affinity Asset Advisors, Llc | 2024-09-30 | 400 K | State Street Corp | 2024-06-30 | 359 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 332.4 K | Northern Trust Corp | 2024-09-30 | 286.6 K | Kennedy Capital Management Inc | 2024-06-30 | 212.2 K | Sio Capital Management, Llc | 2024-06-30 | 133.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 103.6 K | Ubs O'connor Llc | 2024-06-30 | 100.4 K | Susquehanna International Group, Llp | 2024-06-30 | 89.9 K | Vanguard Group Inc | 2024-09-30 | 1.9 M | Bvf Inc | 2024-09-30 | 1.7 M |
Verastem Fundamentals
Return On Equity | -1.37 | ||||
Return On Asset | -0.47 | ||||
Operating Margin | (11.45) % | ||||
Current Valuation | 118.09 M | ||||
Shares Outstanding | 44.51 M | ||||
Shares Owned By Insiders | 0.82 % | ||||
Shares Owned By Institutions | 59.92 % | ||||
Number Of Shares Shorted | 2.46 M | ||||
Price To Earning | (3.02) X | ||||
Price To Book | 15.25 X | ||||
Price To Sales | 17.49 X | ||||
Gross Profit | 2.6 M | ||||
EBITDA | (83.17 M) | ||||
Net Income | (87.37 M) | ||||
Cash And Equivalents | 94.31 M | ||||
Cash Per Share | 0.50 X | ||||
Total Debt | 41.56 M | ||||
Debt To Equity | 0.50 % | ||||
Current Ratio | 4.87 X | ||||
Book Value Per Share | 0.28 X | ||||
Cash Flow From Operations | (86.46 M) | ||||
Short Ratio | 2.31 X | ||||
Earnings Per Share | (3.14) X | ||||
Price To Earnings To Growth | (1.89) X | ||||
Target Price | 11.13 | ||||
Number Of Employees | 73 | ||||
Beta | 0.14 | ||||
Market Capitalization | 174.91 M | ||||
Total Asset | 149.72 M | ||||
Retained Earnings | (824.89 M) | ||||
Working Capital | 117.3 M | ||||
Current Asset | 110.84 M | ||||
Current Liabilities | 10.11 M | ||||
Net Asset | 149.72 M |
About Verastem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Verastem Piotroski F Score and Verastem Altman Z Score analysis. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share 0.331 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (1.37) |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.